Pain Management Alternatives for Patients with Codeine Allergy

Introduction to Pain Management

For patients with a codeine allergy, non-steroidal anti-inflammatory drugs (NSAIDs) are recommended as first-line alternatives for mild to moderate pain, while hydromorphone, morphine, or fentanyl are recommended for moderate to severe pain, as suggested by the American College of Critical Care and the European Society for Medical Oncology 1, 2

The assessment of pain severity should be done using visual analog scales (VAS), verbal rating scales (VRS), or numerical rating scales (NRS) to determine appropriate treatment, according to the European Society for Medical Oncology 3, 4
Pain-related behaviors and discomfort observation should be used in patients with cognitive impairment, as recommended by the European Society for Medical Oncology 4

Acetaminophen/paracetamol (500-1000 mg every 4-6 hours, max 4000 mg/day) can be used for mild pain, as suggested by the European Society for Medical Oncology 5, 6
NSAIDs such as ibuprofen (400-600 mg every 6-8 hours) can be used for mild pain, according to the American College of Critical Care and the European Society for Medical Oncology 1, 5
Diclofenac (50 mg every 6-8 hours) and ketoprofen (25-75 mg every 6-8 hours) are also options for mild pain, as recommended by the European Society for Medical Oncology 5

Tramadol (50-100 mg every 4-6 hours) can be used for mild to moderate pain, but with caution due to potential cross-sensitivity with codeine, as suggested by the European Society for Medical Oncology 2, 7
Dihydrocodeine can be used with caution for mild to moderate pain, but its use is not recommended due to potential cross-sensitivity with codeine, according to the European Society for Medical Oncology and the British Journal of Cancer 2, 8
Low doses of strong opioids in combination with non-opioid analgesics can be used for mild to moderate pain, as recommended by the European Society for Medical Oncology 2, 6

Hydromorphone (0.015 mg/kg IV) is recommended as comparable or potentially superior to morphine for moderate to severe pain, with a quicker onset of action and higher potency, according to the American College of Critical Care 1
Morphine (oral route preferred when possible) can be used for moderate to severe pain, with a recommended dose of 0.1 mg/kg IV, then 0.05 mg/kg at 30 min, maximum 10 mg, as suggested by the European Society for Medical Oncology and the American College of Critical Care 1, 3, 9
Fentanyl (1 mcg/kg, then ~30 mcg every 5 min) can be used for moderate to severe pain, with a shorter onset of action and higher potency than morphine, and is safe for patients with morphine allergies, according to the American College of Critical Care 1
Buprenorphine (transdermal or IV) is a safe option for patients with renal impairment, as recommended by the European Society for Medical Oncology 4

The oral route should be advocated as the first choice when possible, according to the European Society for Medical Oncology 4
For patients unable to take oral medications, consider transdermal (e.g., fentanyl) or continuous parenteral administration, as suggested by the British Journal of Cancer 8
All opioids should be used with caution, at reduced doses and frequency in renal impairment, according to the European Society for Medical Oncology 4
Fentanyl and buprenorphine are the safest opioids for patients with chronic kidney disease stages 4 or 5, as recommended by the European Society for Medical Oncology 4
Prescribe laxatives routinely for prophylaxis and management of opioid-induced constipation, and use metoclopramide or antidopaminergic drugs for opioid-related nausea/vomiting, according to the European Society for Medical Oncology 4

Avoid assuming that all opioids will cross-react with codeine allergy - fentanyl is safe in patients with morphine allergies, as suggested by the American College of Critical Care 1
Be cautious with tramadol in patients with epilepsy risk or those taking antidepressants, according to the British Journal of Cancer 8
Avoid abrupt discontinuation of opioid treatments - taper by 30-50% over about a week, as recommended by the British Journal of Cancer 8
Remember that some weak opioids like codeine have a ceiling effect where increasing doses only increases side effects without improving analgesia, according to the European Society for Medical Oncology 9